Home
Resources
Publications
Treatment of Cutaneous Candidiasis Through Fluconazole Encapsulated Cubosomes

Treatment of Cutaneous Candidiasis Through Fluconazole Encapsulated Cubosomes

Vijay Prajapati, Aakanchha Jain, Richa Jain, Sanjeev Sahu, Dharm Veer Kohli

Drug Deliv Transl Res. 2014 Dec;4(5-6):400-8.

PMID: 25787202

Abstract:

Cubosomes encapsulating fluconazole were prepared by emulsification method and characterized for particle size, entrapment efficiency, SEM, in vitro release, skin irritation studies, and confocal laser scanning microscopy. The cubosomes prepared were 257.2 ± 2.94 nm in size and with drug entrapment efficiency of 66.2 ± 2.69 %. The prepared formulation was characterized for surface morphology by SEM analysis which revealed their smooth surface. The cumulative percentage of fluconazole from cubosomes permeated via dialysis membrane (molecular weight cutoff (MWCO) 12-14 kD) showed 76.86 % cumulative drug release, while fluconazole solution showed release up to 91.04 % in 24 h in phosphate-buffered saline (PBS) (pH 6.5), and sustained release is obtained after 24 h in case of cubosomes. The animal studies also revealed that the cubosomes are non-irritant and have sustained antifungal activity.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP86386734-A	Fluconazole solution		86386-73-4	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: